MELIORA Data Collection Campaigns
Condition(s) studied
Investigational drug(s) / intervention(s)
Data Collection campaign: Participants will be asked to download the MELIROA app, compatible with iOS and Android, to their smartphones and test it for 14 days. The app will prompt the user to set a weekly goal on physical activity and support daily self-monitoring and step count tracking. Τhe app will also offer culturally adapted educational material through mini-courses, motivational and practical tips and an embedded library of materials relevant to physical activity, healthy diet and alcohol consumption. To boost motivation, it will also include reminders and gamification features like badges and points.
Study summary
To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors. Each participant is asked to test and evaluate a preliminary version of the MELIORA app over a 14-day period. The DCC takes place in the early stages of the project, as part of the intervention development phase, to inform the technical refinement and preliminary evaluation of the MELIORA digital app.
Eligibility
Primary outcome measure(s)
- Usability — 14 days
Assessment of the usability of the first versions of the MELIORA app and users' feedback for further refinement. Participants' experiences and evaluations of the MELIORA app will be collected through a 29-item questionnaire developed for the purposes of the study. Initial questionnaire items were based on the mHealth App Usability Questionnaire (MAUQ) and the Trust in Technology framework, with additional items included to allow evaluations of specific app features. The questionnaire comprises 27 close-ended (with a 1-5 rating Likert scale) and 2 open-ended questions aiming to explore the usability and usefulness of the app, and participants' overall satisfaction with it. - Relevance, appropriateness and usefulness — 14 days
Users' feedback on the relevance, appropriateness and usefulness of the MELIORA app's educational content and format. Participants will be asked to evaluate the educational materials received, through a pop-up form which will occur at the end of their interaction with each material. The form will contain four questions (with a 1 to 5 rating Likert scale) aiming to gain participants' feedback on the usefulness, relevance, and comprehensibility of the provided materials
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| Harokopio University | Athens | Greece | Recruiting |
| Lietuvos Sveikatos Mokslų Universitetas (Lsmu) | Kaunas | Lithuania | Recruiting |
| Pagalbos Onkologiniams Ligoniams Asociacija (Pola L T) | Kaunas | Lithuania | Recruiting |
| Fundación Para El Fomento de La Investigación Sanitaria Y Biomédica de La Comunitat Valenciana (Fisabio) | Valencia | Spain | Recruiting |
| INCLIVA - Instituto de Investigación Sanitaria | Valencia | Spain | Recruiting |
| Bröstcancerföreningen Amazona I Stockholms Län (Amazona) | Stockholm | Sweden | Recruiting |
| Karolinska Institutet | Stockholm | Sweden | Recruiting |
More Harokopio University trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07190066 on ClinicalTrials.gov ↗ ← All trials in Sweden